ACOG: Updated Clinical Guidance for the Use of Progesterone Supplementation for the Prevention of Recurrent Preterm Birth
Updated Clinical Guidance for the Use of Progesterone Supplementation for the Prevention of Recurrent Preterm Birth…
ACOG: Association of Primary Cesarean Delivery Rate With Dissemination of Nurse-Specific Cesarean Delivery Rates
Association of Primary Cesarean Delivery Rate With Dissemination of Nurse-Specific Cesarean Delivery Rates Strategies to safely reduce the rate of nulliparous, term, singleton, vertex (NTSV) cesarean deliveries have thus far…
ACOG: Defining a Cesarean Delivery Rate for Optimizing Maternal and Neonatal Outcomes
Defining a Cesarean Delivery Rate for Optimizing Maternal and Neonatal Outcomes After the global cesarean delivery rate nearly doubled between 2000 and 2015, cesarean deliveries now account for nearly one…
Read More from ACOG: Defining a Cesarean Delivery Rate for Optimizing Maternal and Neonatal Outcomes
ACOG: Progression to Severe Chronic Hypertension 5–7 Years After a Pregnancy With Mild Chronic Hypertension
Progression to Severe Chronic Hypertension 5–7 Years After a Pregnancy With Mild Chronic Hypertension OBJECTIVE: To estimate the incidence of severe chronic hypertension (cHTN) within 5–7 years after a pregnancy…
ACOG: Racial and Ethnic Disparities in Primary Cesarean Birth and Adverse Outcomes Among Low-Risk Nulliparous People
Racial and Ethnic Disparities in Primary Cesarean Birth and Adverse Outcomes Among Low-Risk Nulliparous People OBJECTIVE: To compare trend of primary cesarean delivery rate and composite neonatal and maternal adverse…
ACOG: Urine Drug Screening for Isolated Marijuana Use in Labor and Delivery Units
Urine Drug Screening for Isolated Marijuana Use in Labor and Delivery Units Isolated marijuana use is frequently used as an indication for urine drug screening in labor and delivery…
Read More from ACOG: Urine Drug Screening for Isolated Marijuana Use in Labor and Delivery Units
ACOG: Using Longitudinally Linked Data to Measure Severe Maternal Morbidity Beyond the Birth Hospitalization in California
Using Longitudinally Linked Data to Measure Severe Maternal Morbidity Beyond the Birth Hospitalization in California Most studies of severe maternal morbidity (SMM) include only cases that occur during birth hospitalizations….
ACOG: Pregnancy-Associated Homicide and Suicide
Pregnancy-Associated Homicide and Suicide OBJECTIVE: To analyze differences in the demographic and social factors associated with pregnancy-associated violent deaths due to homicide compared with suicide by pregnancy timing. METHODS: This…
Read More from ACOG: Pregnancy-Associated Homicide and Suicide
ACOG: A Primer on Monkeypox Virus for Obstetrician–Gynecologists | Diagnosis, Prevention, and Treatment
ABSTRACT Since May 2022, more than 6,900 cases of monkeypox virus infection have been reported in 52 countries. The World Health Organization is planning to rename the virus and its…
ACOG releases COVID-19 Vaccine PSA and Information
The American College of Obstetricians and Gynecologist (ACOG) just released its first-ever public service announcement (PSA)! Please help spread this important, life-saving message to get vaccinated during pregnancy by sharing: https://www.acog.org/…/COVID-19-Vaccines-Safe-Proven… We know…
Read More from ACOG releases COVID-19 Vaccine PSA and Information
ACOG Practice Advisory: COVID-19 Vaccination Considerations for Obstetric–Gynecologic Care
This Practice Advisory was developed by the American College of Obstetricians and Gynecologists’ Immunization, Infectious Disease, and Public Health Preparedness Expert Work Group in collaboration with Laura E. Riley, MD;…
ACOG: COVID-19 Vaccines and Pregnancy: Conversation Guide
Key Recommendations The American College of Obstetricians and Gynecologists (ACOG) strongly recommends that pregnant individuals be vaccinated against COVID-19. Given the potential for severe illness and death during pregnancy, completion…
Read More from ACOG: COVID-19 Vaccines and Pregnancy: Conversation Guide
ACOG Practice Advisory: Low-Dose Aspirin Use for the Prevention of Preeclampsia and Related Morbidity and Mortality
Background Low-dose aspirin has been used during pregnancy most commonly to prevent or delay the onset of preeclampsia 1. The previous recommendation from the American College of Obstetricians and Gynecologists…
ACOG Practice Advisory: Oxygen Supplementation in the Setting of Category II or III Fetal Heart Tracings
Intrauterine resuscitation in the setting of a Category II or III fetal heart tracing is addressed in Practice Bulletin No. 106, “Intrapartum Fetal Heart Rate Monitoring: Nomenclature, Interpretation, and General…
ACOG: What Obstetrician–Gynecologists Should Know About Substance Use Disorders in the Perinatal Period
ABSTRACT Substance use in pregnancy is common; nearly one of five of pregnant individuals have past-month nicotine, alcohol, or illicit substance use, and more than one in 10 meet criteria…
ACOG: Identifying Cases of Severe Maternal Morbidity – Moving Beyond the Delivery Hospitalization
Accounting for adverse events and outcomes related to maternity is fundamental to measuring the health of populations and the systems for delivering medical care. Traditionally, maternal mortality has been such…
ACOG: Pharmacologic Treatment for Perinatal Mental Health Disorders
ABSTRACT A central question for patients and clinicians is whether potential benefits of pharmacologic treatments for perinatal mental health disorders outweigh potential harms. Given lack of consensus on best practices,…
Read More from ACOG: Pharmacologic Treatment for Perinatal Mental Health Disorders
ACOG: Outpatient Cervical Ripening with Balloon Catheters
ABSTRACT OBJECTIVE: To evaluate whether outpatient cervical ripening with a balloon catheter results in a shorter amount of time in the labor and delivery unit when compared with use in…
Read More from ACOG: Outpatient Cervical Ripening with Balloon Catheters
ACOG: Pregnancy-Associated Deaths Due to Drugs, Suicide, and Homicide in the United States, 2010–2019
ABSTRACT OBJECTIVE: To estimate the prevalence of pregnancy-associated deaths due to drugs, suicide, and homicide nationwide from 2010 to 2019. METHODS: Using U.S. death certificate records from 2010 to 2019…
ACOG: Using Longitudinally Linked Data to Measure Severe Maternal Morbidity
ABSTRACT OBJECTIVE: To assess whether application of a standard algorithm to hospitalizations in the prenatal and postpartum (42 days) periods increases identification of severe maternal morbidity (SMM) beyond analysis of…
Read More from ACOG: Using Longitudinally Linked Data to Measure Severe Maternal Morbidity
ACOG: Variations in Low-Risk Cesarean Delivery Rates in the United States Using the SMFM Definition
ABSTRACT OBJECTIVE: To assess variations in low-risk cesarean delivery rates in the United States using the Society for Maternal-Fetal Medicine (SMFM) definition of low-risk for cesarean delivery and to identify…
ACOG: Current State and Future Direction of Postpartum Hemorrhage Risk Assessment
ABSTRACT In the United States, postpartum hemorrhage is a leading preventable cause of maternal mortality and morbidity. To reduce morbidity from postpartum hemorrhage, risk assessment is an important starting point…
Read More from ACOG: Current State and Future Direction of Postpartum Hemorrhage Risk Assessment
ACOG: Association of Skin Incision Type With Postoperative Cesarean Delivery Complications in Morbidly Obese Patients
ABSTRACT OBJECTIVE: To assess whether Pfannenstiel skin incision compared with vertical skin incision was associated with postcesarean delivery wound complications in morbidly obese women. METHODS: We assembled a retrospective cohort…
ACOG: Risk of Recurrent Stillbirth in Subsequent Pregnancies
ABSTRACT OBJECTIVE: To compare the prospective risk of stillbirth between women with and without a stillbirth in their first pregnancy. METHODS: We conducted a cohort study using perinatal data from…
Read More from ACOG: Risk of Recurrent Stillbirth in Subsequent Pregnancies
ACOG: Trends in and Factors Associated With Episiotomy in the Setting of Nonoperative Vaginal Delivery, 2000–2018
INTRODUCTION Episiotomy, an incision through the perineum to facilitate delivery, is a common obstetric procedure.1 For decades, evidence has shown that routine episiotomy has unclear benefit but substantial risk of…
ACOG: Racial and Ethnic Inequities in Cesarean Birth and Maternal Morbidity in a Low-Risk, Nulliparous Cohort
ABSTRACT OBJECTIVE: To evaluate race and ethnicity differences in cesarean birth and maternal morbidity in low-risk nulliparous people at term. METHODS: We conducted a secondary analysis of a randomized trial…
ACOG: Management of Placental Transfusion to Neonates After Delivery
ABSTRACT This review summarizes high-quality evidence supporting delayed umbilical cord clamping to promote placental transfusion to preterm and term neonates. In preterm neonates, delayed cord clamping may decrease mortality and…
Read More from ACOG: Management of Placental Transfusion to Neonates After Delivery
ACOG: Posttraumatic Stress Disorder Symptoms 2 Months After Vaginal Delivery
ABSTRACT OBJECTIVE: To assess the prevalence of posttraumatic stress disorder (PTSD) symptoms and identify characteristics associated with it 2 months after singleton vaginal delivery at or near term. METHODS: We…
Read More from ACOG: Posttraumatic Stress Disorder Symptoms 2 Months After Vaginal Delivery
ACOG: Neutralizing Antibodies and Cytokines in Breast Milk After Coronavirus Disease 2019 (COVID-19) mRNA Vaccination
ABSTRACT OBJECTIVE: To evaluate immune responses to coronavirus disease 2019 (COVID-19) mRNA-based vaccines present in breast milk and transfer of the immune responses to breastfeeding infants. METHODS: We enrolled 30…
SMFM updated, “Provider Considerations for Engaging in COVID-19 Vaccine Counseling With Pregnant and Lactating Patients,” to include the latest information on boosters.
SMFM and ACOG recommend that pregnant people receive a COVID-19 booster shot at least 6 months after their primary series for mRNA-based vaccines (ie, Pfizer or Moderna) and at least…